Oversold

CAH

Valuation45/ 100
Cash flow & growth62/ 100
Upside potential47/ 100
Risk potential27/ 100

CAH's valuation appears fair, fundamentals are above averages and the outlook sends mixed signals, though analyst coverage is limited.

Score change since last week

The score fell 1 point, mainly due to valuation and price changes. Price rose 5.4%, from $234.55 to $247.18. Reported EPS was unchanged, so the higher price reduced valuation support.

Valuation and price changes subtracted 1.0 points. The comparison uses the same available inputs on both dates. Displayed changes are rounded to whole points.

Valuation

Historical cheapness: current PE is 32.4× versus the full-history median of 28× shown in the valuation table, producing 39.9/100. Positive weekly observations receive equal weight; lower past EPS alone does not disqualify them.

Outlook-adjusted valuation: 44.7/100. The model applies a 20.6% earnings-growth assumption and a 10% annual return hurdle, with positive credit limited by evidence coverage and confidence.

Forward price scenarios use recent PE history separately. Recent history has a separately weighted median of 30.7× (18-month half-life). The favorable scenario uses 31.4× PE and $9.4 projected EPS, informed by growth, margins and earnings-quality checks. This is a model scenario, not an analyst target. A return to the full-history median is not assumed.

Cash flow & growth

Business trends are mixed. Over the past year: revenue +14.2%, earnings +12.1%, operating margin +0 percentage points. Free cash flow is 1.8% of revenue. The business score is 61.9/100. Growth, margins and cash generation drive the score. Missing or older data receives less weight.

Favorable scenario

Stronger earnings and valuation could support a higher share price.

Our favorable case uses $9.40 of EPS and a 31.4× PE, suggesting a share price of about $295.28. Valuation history and outlook inform the PE.

The displayed favorable scenario is 25.9% upside, or about $295.32.

This is a scenario based on our model, not a forecast or probability.

Downside scenario

Weaker than expected earnings could put pressure on the share price.

Our downside case uses $6.24 of EPS and a 27.5× PE, suggesting a share price of about $171.80 — 27% below today’s price. Valuation history and outlook inform the PE.

This is a scenario based on our model, not a forecast or probability.

CAH vs Historical averages

MetricCurrentAverageRelative
PE32x36x10% lower
PE percentile695038% higher
EPS$7.23$1.97268% higher
FCF$4.5B$2.5B78% higher
Loading historical comparisons…

CAH’s earnings and cash flow are above their historical averages, while its earnings multiple is lower.

CAH Forward outlook

MetricOutlook
Forward valuationImproving
Forward earningsGrowth
Forward revenueStable
Forward profitabilityStable
Analyst coverageLimited
Estimate dispersionTight

CAH’s outlook is mixed, though analyst coverage is limited.

CAH PE Valuation

Loading pe valuation table…

This table applies CAH's historical price-to-earnings (PE) landmarks to current earnings. The implied prices are valuation scenarios, not price forecasts or targets.

CAH Earnings Per Share

Loading earnings per share…

This chart tracks CAH's trailing twelve-month diluted earnings per share, calculated from four consecutive reported quarters to reduce seasonal noise.

CAH Quarterly Revenue

Loading quarterly revenue…

This chart tracks CAH's quarterly revenue over time and shows how sales are changing from year to year.

CAH Free Cash Flow

Loading free cash flow…

This chart tracks CAH's free cash flow over time, showing whether the business is consistently generating cash after operating costs and capital spending.

CAH Total Shares

Loading shares over time…

This chart tracks changes in CAH's diluted share count. A rising count can dilute existing owners, while a falling count often reflects share repurchases.

CAH Net Leverage

Loading net leverage…

Quarterly Net Leverage uses the last 12 months of EBITDA. A falling multiple generally indicates less debt relative to earnings capacity. Negative values mean net cash; missing data or nonpositive LTM EBITDA are N/A. The table shows each period’s Net Leverage and status.

CAH PE vs Healthcare Sector

Loading pe vs sector average…

This chart compares CAH's price-to-earnings (PE) ratio with the Healthcare sector average. A discount or premium can reflect differences in expected growth, profitability, or risk.

CAH Weekly Price

Loading weekly price…

This chart uses CAH's weekly closing prices to show the longer-term trend. The lower panes show weekly RSI and Stochastic momentum.

CAH Weekly Moving Averages

Loading weekly moving averages…

This chart compares CAH's 8, 20, 50, 100, and 200-week moving averages from 2020 onward. Shorter averages react faster to price changes, while longer averages show the broader trend.

CAH Yearly ROI

Loading yearly ROI…

Each line starts at 0% using the year’s first dependable weekly close and tracks the return through December, or through the latest available week for the current year.